Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein therapeutics.
Sera Medicines has raised $38.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in June 2026.
Sera Medicines is headquartered in Boston, United States.
Sera Medicines is an operator of biologics accelerator developing and launching next-generation protein therapeutics.
Sera Medicines is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sera Medicines — Funding & Investors." VCBacked, June 16, 2026, https://www.vcbacked.co/company/sera-medicines. Accessed August 14, 2026.
VCBacked. (2026). Sera Medicines — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/sera-medicines
{{cite web |title=Sera Medicines — Funding & Investors |url=https://www.vcbacked.co/company/sera-medicines |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated